Oticon Real vs Otofonix Encore

The Oticon Real is a premium prescription behind-the-ear hearing aid released in 2023, priced at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.7/5, placing it in the top 10% of the 39 prescription hearing aids tested and ranking #5 in its category. Speech performance is a clear strength for the Oticon Real. Speech in quiet scored a strong 4.0/5, sitting 0.64 points above the category average. Speech in noise measured 2.9/5—above the category average by 0.82 points, though still mixed in absolute terms. This combination makes it a solid choice for listeners prioritizing conversation clarity across different environments. Feedback handling scored a strong 4.0/5 in absolute terms, though this falls 0.72 points below the category average of 4.72/5. Own voice comfort scored 2.4/5, which is 0.30 points below the category average—a potential consideration for those sensitive to how their own voice sounds. Music streaming performance was mixed at 2.8/5, essentially matching the category average. The Oticon Real is a two-time Expert's Choice Award winner (2023, 2024) and offers flexible power options with both rechargeable and disposable batteries. It supports iPhone and Android streaming along with hands-free calling. Within its premium price tier, it faces strong competition from devices like the Phonak Sphere Infinio and Oticon Intent, but remains a compelling option for users who prioritize speech intelligibility and are willing to invest in top-tier technology.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.